Valproic Acid

Valproic acid affects chemicals in the body that may be involved in causing seizures. Valproic acid is used to treat various types of seizure disorders. Valproic acid is sometimes used together with other seizure medications. Valproic acid is also used to treat manic episodes related to bipolar disorder (manic depression), and to prevent migraine headaches. Valproic acid may also be used for purposes not listed in this medication guide.

Certificate of Analysis

  • Description

    A colourless or very slightly yellow, clear liquid, slightly viscous..

    Result

    A clear colourless liquid.

  • Solubility

    Very slightly soluble in water, miscible with alcohol & with methylene chloride.

    Result

    Complies

  • Identification

    Should comply the test A & B.

    Result

    A & B Complies.

  • Water

    Not more than 1 %

    Result

    0.46 %

  • Related Substance by HPLC
    Indivisual Impurity

    Not more than 0.05 %

    Result

    Not more than 0.05 %

  • Related Substance by HPLC
    Sum of all secondary impurities

    Not more than 0.2 %

    Result

    Not more than 0.2 %

  • Heavy Meals

    NMT 0.002 %

    Result

    Less than 0.002 %

  • Residue on ignition

    NMT 0.1 %

    Result

    0.02%

  • Assay

    Between 99.0 % to 101 %

    Result

    99.92 %

  • Specific gravity (Density)

    0.89 to 0.91

    Result

    0.90

  • Residual Solvent
    Result

    NIL

Note: Note: – We are leading channel partner of much API manufacturer, supplier & exporters and Pharmaceutical raw material in Colombo, Chili, Ecuador and Globally.

Material Safety Data Sheet

  • Section 1 – Chemical Product

    Product Identifier

    Valproic Acid

    MSDS Prepared By

    R&D Department

  • Section 2 – Composition / Information Of Ingredients

    Product Name

    Valproic Acid

    Synonym

    Dipropylacetic acid; Valproic acid

    Molecular Formula

    C8H16O2

    Molecular Weight

    144.21

    CAS Number

    99-66-1

  • Section 3 – HAZARDOUS IDENTIFICATION

    Emergency Overview

    Harmful if swallowed.

    Health Effects

    Eye

    Causes eye burns.

    Skin

    Causes skin burns.

    Ingestion

    Harmful if swallowed. Causes gastrointestinal tract burns.

    Inhalation

    Causes chemical burns to the respiratory tract. Chronic: Possible risk of harm to the unborn child.

  • Section 4 – FIRST AID

    Skin Contact

    Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.

    Eye Contact

    Immediately flush eyes with plenty of water for at least 15 Minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.

    Inhalation

    Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.

    Ingestion

    Do not induce vomiting. Get medical aid immediately.

    Notes to Physician

    Treat symptomatically.

  • Section 5 – FIRE FIGHTING MEASURES

    General Information

    As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.

    Extinguishing Media

    Use foam, dry chemical, or carbon dioxide.

  • Section 6 – ACCIDENT RELEASE MEASURES

    General Information

    Use proper personal protective equipment as Indicated in Section 8.

    Spills/Leaks

    Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

  • Section 7 – HANDLING AND STORAGE

    Handling

    Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.

    Storage

    Store in a cool, dry place. Store in a tightly closed container away from Corrosive area.

  • Section 8 – EXPOSURE CONTROLS / PERSONAL PROTECTION

    Engineering Controls

    Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.

    Personal Protective Equipment 

    Eye Protection

    Wear chemical goggles.

    Skin

    Wear appropriate protective gloves to prevent Skin exposure.

    Clothing

    Wear appropriate protective clothing to prevent skin exposure.

    Respirators

    Follow the OSHA respirator regulations found in 29 CFR 1910. 134 or European Standard EN 149. Always use a NIOSH or European Standard EN 149 approved respirator when necessary.

  • Section 9 – PHYSICAL AND CHEMICAL PROPERITIES

    Physical State

    Clear liquid

    Colour

    Colourless

    Odor

    N/A

    pH

    N/A

    Vapor Pressure

    N/A

    Viscosity

    N/A

    Boiling Point

    220 ° C

    Melting Range

    N/A

    Auto-ignition Temperature

    N/A

    Flash Point

    111 ° C

    Explosion Limits, lower

    N/A

    Explosion Limits, upper

    N/A

    Decomposition Temperature

    N/A

    Solubility in Water

    Slightly soluble.

    Specific Gravity/ Density

    0.920

  • Section 10 – STABILITY AND REACTIVITY

    Chemical stability

    N/A

    Conditions to avoid

    N/A

    Incompatibilities with Other Materials

    Oxidizing agents, reducing agents, bases.

    Hazardous Decomposition Products

    Carbon monoxide, carbon dioxide.

    Hazardous Polymerization

    Will not occur.

  • Section 11 – TOXICOLOGICAL INFORMATION

    RTECS#:

    CAS# 99-66-1

    LD50/LC50:

    CAS# 99-66-1

    Oral, mouse: LD50 = 1098 mg/kg;

    Oral, rat

    LD50 = 670 mg/kg.

    Carcinogenicity

    2-Propylpentanoic acid -Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA. See actual entry in RTECS for complete information.

  • Section 12 – ECOLOGICAL INFORMATION

    No data Available.

  • Section 13 – DISPOSAL CONSIDERATION

    General Information

    Dispose of in a manner consistent with federal, state, and local regulations.

  • Section 14 – TRANSPORT INFORMATION

    DOT

    Not regulated as hazardous material by DOT.

    IATA

    Not regulated as dangerous goods.

  • Section 15 – REGULATORY INFORMATION

    European/International Regulations

    Directives Hazard Symbols

    T

    Risk Phrases

    R61

    May cause harm to the unborn child.

    R22

    Harmful if swallowed

    R34

    Causes burns.

    Safety Phrases

    S53

    Avoid exposure – obtain special instructions before use.

    S26

    In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.

    S36/37/39

    Wear suitable protective clothing, Gloves and eye/face protection.

    S45

    In case of accident or if you feel unwell, seek medical advice immediately (show the label Where possible).

    WGK (Water Danger/Protection)

    CAS# 99-66-1

    No information available. United Kingdom Occupational Exposure Limits United Kingdom Maximum Exposure Limits Canada. None of the chemicals in this product are listed on the DSL/NDSL list.CAS# 99-66-1 is not listed on Canada’s Ingredient Disclosure List.

    Exposure Limits US FEDERAL TSCA

    CAS# 99-66-1

    Is not listed on the TSCA inventory. It is for research and development use only.

  • Section 16 – OTHER INFORMATION

    Global Pharma provides information contained herein in good faith but makes no representation as to its comprehensives or accuracy. This document is intended only as a guide to the appropriate precautionary handling of the material by a properly trained person using this product.

    Individuals receiving the information must exercise their independent judgment in determining its appropriateness for a particular purpose.

    GLOBAL PHARMA MAKES NO REPRESENTATIONS OR WARRANTIES, EITHER EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY WARRANTIES OR MERCHANTABILITY, FITNESS FOR A PARTICULER PURPOSE WITH RESPECT TO THE INFORMATION SET FORTH HEREIN OR THE PRODUCT WHICH THE INFORMATION REEFERS. GLOBAL PHARMA WILL NOT BE RESPONSIBLE FOR DAMAGES RESULTING FROM USE OF RELIANCE UPON THIS INFORMATION.

WhatsApp
+91 9819994077